Sung H Chun, MD
Cardiac Electrophysiology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 2
Offices
2 locations · Physician Services at El Camino Hospital · Sutter Bay Medical Foundation
Looking this up.
Hospitals listed: El Camino Health · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chun’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G69787 · Current
Licensed to practise in California · since 1990 · expires 2027-10-31 · George Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$309,210
Medicare paid this office $309,210 for 1,600 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 360 | $96,939 | $159 |
| Return visit (30+ min) | 209 | $30,803 | $111 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 85 | $30,207 | $67 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 49 | $21,928 | $448 |
| New patient visit (60+ min) | 95 | $18,328 | $193 |
See all 26 services
| Long return visit (40+ min) | 360 | $96,939 | $159 |
| Return visit (30+ min) | 209 | $30,803 | $111 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 85 | $30,207 | $67 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 49 | $21,928 | $448 |
| New patient visit (60+ min) | 95 | $18,328 | $193 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 480 | $15,970 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 386 | $13,920 | $24 |
| Programming of dual lead pacemaker system | 114 | $12,202 | $77 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 21 | $5,871 | $255 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 97 | $4,544 | $30 |
| External shock to heart to regulate heart beat | 34 | $3,620 | $98 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 371 | $3,386 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 36 | $3,213 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 245 | $3,189 | $13 |
| Programming of dual lead implantable defibrillator system | 24 | $2,822 | $97 |
| Evaluation of cardiac rhythm monitor system | 28 | $2,594 | $50 |
| Programming of multiple lead pacemaker system | 16 | $2,474 | $82 |
| Programming of multiple lead implantable defibrillator system | 15 | $2,413 | $105 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 83 | $1,959 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 83 | $1,105 | $13 |
| Hospital discharge day management, 30 minutes or less | 14 | $1,043 | $74 |
| Insertion of heart rhythm monitor under skin | 12 | $740 | $62 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $336 | $15 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $227 | $21 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $143 | $13 |
| Blood test, clotting time | 23 | $130 | $4 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
1,600 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 27% · Women 48% · Also on Medicaid 12% · Health risk score 1.38. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 73% · Atrial fibrillation 54% · Coronary heart disease 35% · Heart failure 29% · Chronic kidney disease 28% · Diabetes 25% · Cancer 19% · Depression 18% · Dementia 12% · COPD 11% · Stroke 11%.
The office billed $1,284,761, Medicare allowed $412,506 and paid $309,210; for 4,504 services of 70 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,600 | 4,504 | 79 | 1.38 | $1,284,761 | $309,210 |
| 2023 | 1,446 | 3,857 | 79 | 1.35 | $1,051,642 | $260,573 |
| 2022 | 1,464 | 4,223 | 79 | 1.39 | $1,237,540 | $317,244 |
| 2021 | 1,501 | 3,667 | 78 | 1.41 | $1,140,544 | $314,024 |
| 2020 | 1,249 | 2,977 | 78 | 1.42 | $773,591 | $199,315 |
| 2019 | 1,471 | 3,602 | 78 | 1.44 | $1,001,616 | $242,027 |
| 2018 | 1,409 | 3,129 | 77 | 1.36 | $1,060,732 | $257,005 |
| 2017 | 1,615 | 3,250 | 77 | 1.30 | $931,928 | $227,215 |
| 2016 | 1,165 | 2,663 | 77 | 1.24 | $838,701 | $211,334 |
| 2015 | 1,197 | 2,815 | 77 | 1.17 | $856,574 | $218,359 |
| 2014 | 1,103 | 2,640 | 77 | 1.18 | $890,381 | $220,212 |
| 2013 | 1,095 | 3,021 | 77 | 1.25 | $881,129 | $213,572 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 32 services
| Long return visit (40+ min) | 279 | $75,053 | $156 |
| Return visit (30+ min) | 271 | $39,796 | $113 |
| New patient visit (60+ min) | 85 | $16,952 | $199 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 42 | $16,071 | $383 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 382 | $11,493 | $23 |
| Programming of dual lead pacemaker system | 101 | $11,204 | $81 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 309 | $9,967 | $25 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 61 | $9,327 | $62 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,954 | $464 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 18 | $4,287 | $238 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 35 | $3,358 | $58 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 60 | $3,290 | $22 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 76 | $3,091 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 228 | $2,993 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 321 | $2,917 | $7 |
| Programming of dual lead implantable defibrillator system | 21 | $2,619 | $101 |
| New patient visit (45+ min) | 16 | $2,577 | $161 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,408 | $105 |
| Programming of multiple lead pacemaker system | 16 | $2,327 | $86 |
| External shock to heart to regulate heart beat | 21 | $2,264 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,239 | $160 |
| Evaluation of cardiac rhythm monitor system | 21 | $2,216 | $53 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 68 | $1,599 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,536 | $110 |
| Insertion of heart rhythm monitor under skin | 21 | $1,453 | $69 |
| Programming of single lead pacemaker system | 11 | $990 | $71 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $912 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 64 | $838 | $13 |
| Blood test, clotting time | 56 | $563 | $4 |
| Anticoagulant management of patient taking warfarin | 25 | $314 | $7 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 11 | $238 | $22 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 11 | $149 | $14 |
2022: 33 services
| Long return visit (40+ min) | 275 | $80,884 | $163 |
| Return visit (30+ min) | 302 | $46,774 | $110 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 43 | $35,172 | $782 |
| New patient visit (60+ min) | 103 | $21,149 | $205 |
| Programming of dual lead pacemaker system | 121 | $12,766 | $85 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 331 | $10,900 | $24 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $9,916 | $451 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 32 | $9,078 | $267 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 261 | $8,955 | $26 |
| Programming of dual lead implantable defibrillator system | 30 | $4,084 | $102 |
| External shock to heart to regulate heart beat | 25 | $3,354 | $96 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 41 | $3,283 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 360 | $3,246 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 72 | $3,237 | $32 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 115 | $3,174 | $25 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 247 | $3,127 | $12 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 46 | $2,899 | $25 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 46 | $2,704 | $23 |
| Programming of multiple lead pacemaker system | 19 | $2,292 | $88 |
| Hospital observation care on day of discharge | 30 | $2,016 | $67 |
| Heart rhythm recording of continous external ekg over 8-15 days | 109 | $1,871 | $15 |
| Programming of multiple lead implantable defibrillator system | 13 | $1,790 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $1,583 | $88 |
| Programming of single lead pacemaker system | 17 | $1,381 | $69 |
| New patient visit (45+ min) | 11 | $1,366 | $124 |
| Evaluation of cardiac rhythm monitor system | 16 | $1,196 | $54 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 53 | $1,167 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $1,005 | $77 |
| Insertion of heart rhythm monitor under skin | 12 | $930 | $78 |
| Anticoagulant management of patient taking warfarin | 44 | $785 | $9 |
| Blood test, clotting time | 60 | $751 | $4 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $671 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 19 | $270 | $13 |
2021: 30 services
| Long return visit (40+ min) | 306 | $90,770 | $160 |
| Return visit (30+ min) | 268 | $44,643 | $121 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 43 | $33,053 | $751 |
| New patient visit (60+ min) | 97 | $18,949 | $195 |
| Programming of dual lead pacemaker system | 134 | $15,411 | $79 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 43 | $12,911 | $287 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 48 | $10,058 | $205 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $6,670 | $476 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 219 | $6,323 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 135 | $3,926 | $27 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 43 | $3,831 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 263 | $3,779 | $14 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 378 | $3,685 | $8 |
| Programming of multiple lead implantable defibrillator system | 19 | $3,071 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,961 | $96 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 83 | $2,917 | $21 |
| External shock to heart to regulate heart beat | 24 | $2,886 | $103 |
| Programming of dual lead implantable defibrillator system | 24 | $2,704 | $100 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 73 | $2,604 | $32 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 29 | $2,308 | $58 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 86 | $2,237 | $25 |
| Hospital observation care on day of discharge | 31 | $2,175 | $68 |
| Programming of multiple lead pacemaker system | 18 | $2,124 | $82 |
| Programming of single lead pacemaker system | 21 | $1,720 | $69 |
| Heart rhythm recording of continous external ekg over 8-15 days | 79 | $1,337 | $16 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 34 | $1,040 | $21 |
| Insertion of heart rhythm monitor under skin | 12 | $909 | $76 |
| Blood test, clotting time | 82 | $716 | $4 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 11 | $383 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 21 | $266 | $13 |
2020: 32 services
| Return visit (30+ min) | 333 | $51,595 | $96 |
| Long return visit (40+ min) | 99 | $15,354 | $125 |
| New patient visit (60+ min) | 65 | $12,210 | $188 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 22 | $11,877 | $540 |
| Telephone medical discussion with physician, 21-30 minutes | 58 | $7,852 | $106 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $6,574 | $470 |
| Programming of dual lead pacemaker system | 87 | $6,435 | $65 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 199 | $6,121 | $26 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 31 | $5,192 | $167 |
| Short return visit (20+ min) | 61 | $5,136 | $68 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 22 | $4,615 | $210 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 143 | $3,933 | $25 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,813 | $318 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 225 | $3,597 | $16 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 257 | $2,614 | $8 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 64 | $2,607 | $20 |
| Telephone medical discussion with physician, 11-20 minutes | 30 | $2,215 | $71 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 53 | $2,025 | $31 |
| Programming of dual lead implantable defibrillator system | 21 | $1,917 | $80 |
| External shock to heart to regulate heart beat | 16 | $1,888 | $105 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 39 | $1,830 | $43 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,793 | $90 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 25 | $1,559 | $62 |
| Programming of multiple lead implantable defibrillator system | 11 | $1,390 | $99 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 53 | $1,311 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 39 | $1,110 | $28 |
| Blood test, clotting time | 85 | $830 | $4 |
| Hospital observation care on day of discharge | 11 | $758 | $69 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 20 | $696 | $22 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 11 | $611 | $56 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 14 | $437 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $155 | $14 |
2019: 32 services
| Return visit (30+ min) | 353 | $57,706 | $95 |
| Long return visit (40+ min) | 116 | $23,028 | $130 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 27 | $20,117 | $745 |
| New patient visit (60+ min) | 66 | $12,685 | $192 |
| Programming of dual lead pacemaker system | 122 | $9,994 | $60 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 38 | $8,193 | $216 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 27 | $7,618 | $282 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,804 | $454 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 411 | $6,584 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 86 | $5,412 | $42 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 158 | $4,486 | $25 |
| Programming of dual lead implantable defibrillator system | 33 | $3,714 | $81 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 91 | $3,537 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 361 | $3,473 | $8 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 116 | $3,216 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 32 | $2,793 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,764 | $184 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 28 | $2,408 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,368 | $95 |
| Programming of multiple lead implantable defibrillator system | 17 | $2,059 | $90 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 41 | $1,746 | $41 |
| External shock to heart to regulate heart beat | 14 | $1,636 | $102 |
| Programming of heart rhythm stimulation after drug infusion | 11 | $1,558 | $142 |
| External ekg recording for more than 48 hours up to 21 days | 55 | $1,547 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 55 | $1,353 | $24 |
| Blood test, clotting time | 124 | $1,318 | $4 |
| Hospital observation care on day of discharge | 19 | $1,288 | $68 |
| Programming of single lead pacemaker system | 22 | $1,225 | $51 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 11 | $1,145 | $104 |
| Programming of multiple lead pacemaker system | 11 | $757 | $63 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $492 | $22 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 19 | $303 | $12 |
2018: 31 services
| Return visit (30+ min) | 345 | $57,718 | $92 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 51 | $34,082 | $643 |
| Long return visit (40+ min) | 82 | $13,708 | $136 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 51 | $13,037 | $246 |
| New patient visit (60+ min) | 68 | $12,773 | $188 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 28 | $12,740 | $455 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 60 | $12,229 | $194 |
| Programming of dual lead pacemaker system | 125 | $8,830 | $52 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 483 | $7,177 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 153 | $4,300 | $26 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 12 | $4,181 | $322 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 53 | $4,008 | $73 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 76 | $3,933 | $34 |
| Programming of dual lead implantable defibrillator system | 39 | $3,704 | $69 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 39 | $3,281 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 296 | $2,717 | $7 |
| External shock to heart to regulate heart beat | 19 | $2,522 | $101 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 92 | $2,504 | $25 |
| Programming of multiple lead implantable defibrillator system | 17 | $2,293 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $2,060 | $94 |
| Programming of heart rhythm stimulation after drug infusion | 17 | $2,016 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,001 | $182 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $1,859 | $81 |
| New patient visit (45+ min) | 11 | $1,684 | $153 |
| External ekg recording for more than 48 hours up to 21 days | 55 | $1,572 | $28 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $1,420 | $47 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 55 | $1,373 | $25 |
| Hospital observation care on day of discharge | 14 | $1,137 | $67 |
| Programming of single lead pacemaker system | 21 | $1,033 | $40 |
| Programming of dual lead pacemaker system | 11 | $384 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $175 | $13 |
2017: 30 services
| Return visit (30+ min) | 345 | $55,361 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 40 | $21,662 | $542 |
| New patient visit (60+ min) | 74 | $13,596 | $184 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 647 | $10,180 | $15 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 47 | $9,578 | $204 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 20 | $9,044 | $431 |
| Insertion of implantable defibrillator system | 11 | $8,434 | $767 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 38 | $8,116 | $214 |
| Programming of dual lead pacemaker system | 116 | $7,297 | $52 |
| Programming of dual lead implantable defibrillator system | 38 | $5,414 | $74 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 83 | $5,144 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 153 | $4,517 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,445 | $181 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 35 | $3,418 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 326 | $3,211 | $8 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 39 | $3,094 | $79 |
| Programming of multiple lead implantable defibrillator system | 19 | $2,740 | $86 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 41 | $2,592 | $63 |
| Long return visit (40+ min) | 19 | $2,436 | $128 |
| New patient visit (45+ min) | 16 | $2,432 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,150 | $93 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 74 | $2,101 | $26 |
| Programming of single lead pacemaker system | 30 | $1,855 | $45 |
| External ekg recording for more than 48 hours up to 21 days | 66 | $1,848 | $28 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 66 | $1,607 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 25 | $1,543 | $57 |
| External shock to heart to regulate heart beat | 11 | $981 | $89 |
| Hospital observation care on day of discharge | 11 | $730 | $66 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 12 | $321 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $175 | $13 |
2016: 30 services
| Return visit (30+ min) | 328 | $61,301 | $93 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 31 | $18,909 | $556 |
| Programming of dual lead pacemaker system | 125 | $10,215 | $52 |
| Insertion of implantable defibrillator system | 11 | $8,545 | $777 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 571 | $8,316 | $14 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 36 | $8,186 | $210 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 30 | $6,837 | $207 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 94 | $5,084 | $33 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,725 | $175 |
| Programming of dual lead implantable defibrillator system | 40 | $4,675 | $75 |
| New patient visit (45+ min) | 31 | $4,553 | $147 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 143 | $4,401 | $27 |
| New patient visit (60+ min) | 19 | $3,599 | $189 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,302 | $300 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 40 | $3,174 | $58 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,750 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $2,500 | $89 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 69 | $2,133 | $28 |
| Programming of single lead pacemaker system | 36 | $2,130 | $46 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 30 | $2,027 | $60 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 28 | $2,010 | $67 |
| Programming of multiple lead implantable defibrillator system | 19 | $1,721 | $75 |
| Long return visit (40+ min) | 11 | $1,481 | $135 |
| External shock to heart to regulate heart beat | 11 | $1,224 | $111 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $870 | $72 |
| Programming of single lead implantable defibrillator system | 11 | $866 | $58 |
| Hospital observation care on day of discharge | 13 | $856 | $66 |
| External ekg recording for more than 48 hours up to 21 days | 24 | $614 | $26 |
| Short return visit (20+ min) | 13 | $597 | $46 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 24 | $551 | $23 |
2015: 29 services
| Return visit (30+ min) | 335 | $67,581 | $97 |
| Programming of dual lead pacemaker system | 167 | $17,206 | $57 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 36 | $16,355 | $442 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 564 | $9,087 | $16 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 41 | $7,600 | $177 |
| New patient visit (45+ min) | 45 | $7,148 | $159 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 36 | $6,124 | $166 |
| Programming of dual lead implantable defibrillator system | 36 | $5,342 | $80 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $4,663 | $333 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 123 | $3,975 | $26 |
| Long return visit (40+ min) | 23 | $3,694 | $142 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,607 | $190 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 63 | $3,136 | $36 |
| Short return visit (20+ min) | 33 | $3,050 | $68 |
| Programming of single lead pacemaker system | 38 | $2,682 | $49 |
| Programming of multiple lead implantable defibrillator system | 17 | $2,651 | $88 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 31 | $2,513 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,437 | $97 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 37 | $2,312 | $56 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 35 | $2,183 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 23 | $1,996 | $87 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 56 | $1,825 | $29 |
| External shock to heart to regulate heart beat | 13 | $1,757 | $117 |
| External ekg recording for more than 48 hours up to 21 days | 54 | $1,508 | $27 |
| Programming of single lead implantable defibrillator system | 14 | $1,396 | $63 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 54 | $1,348 | $25 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $770 | $64 |
| Hospital observation care on day of discharge | 12 | $761 | $63 |
| Programming of dual lead pacemaker system | 12 | $439 | $37 |
2014: 28 services
| Return visit (30+ min) | 318 | $57,772 | $90 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 27 | $18,084 | $646 |
| Programming of dual lead pacemaker system | 168 | $15,497 | $53 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 52 | $12,166 | $230 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 41 | $9,976 | $232 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $8,429 | $562 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 501 | $7,351 | $14 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 27 | $6,793 | $243 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,726 | $448 |
| New patient visit (45+ min) | 45 | $6,339 | $141 |
| Short return visit (20+ min) | 79 | $5,462 | $59 |
| Programming of dual lead implantable defibrillator system | 41 | $4,938 | $72 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 137 | $4,629 | $25 |
| Programming of multiple lead implantable defibrillator system | 21 | $3,156 | $83 |
| Long return visit (40+ min) | 22 | $2,721 | $118 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 84 | $2,710 | $28 |
| Programming of single lead pacemaker system | 34 | $2,590 | $44 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 27 | $2,436 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,158 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,033 | $92 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 29 | $1,854 | $58 |
| Programming of single lead implantable defibrillator system | 15 | $1,848 | $58 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 17 | $1,589 | $57 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,497 | $83 |
| Hospital observation care on day of discharge | 20 | $1,370 | $65 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 33 | $1,358 | $33 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 15 | $1,279 | $80 |
| Programming of heart rhythm stimulation after drug infusion | 12 | $957 | $80 |
2013: 31 services
| Return visit (30+ min) | 293 | $57,403 | $90 |
| Programming of dual lead pacemaker system | 151 | $13,914 | $52 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 12 | $12,874 | $920 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $8,268 | $689 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 20 | $7,392 | $321 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 429 | $6,868 | $16 |
| Insertion of catheters for recording and pacing of right heart chambers rhythm and induction of abnormal rhythm | 13 | $6,168 | $474 |
| Programming of dual lead implantable defibrillator system | 39 | $5,700 | $71 |
| Short return visit (20+ min) | 70 | $5,584 | $61 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $5,172 | $431 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 12 | $4,481 | $345 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $4,197 | $81 |
| Long return visit (40+ min) | 32 | $4,119 | $129 |
| New patient visit (45+ min) | 29 | $4,007 | $138 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 144 | $3,618 | $16 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 110 | $3,591 | $25 |
| Programming of multiple lead implantable defibrillator system | 22 | $3,117 | $82 |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 12 | $2,934 | $245 |
| Programming of single lead pacemaker system | 35 | $2,896 | $45 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 49 | $2,243 | $33 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 66 | $2,083 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,997 | $166 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 11 | $1,989 | $166 |
| Blood test, clotting time | 197 | $1,757 | $5 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 19 | $1,594 | $59 |
| Hospital observation care on day of discharge | 19 | $1,468 | $64 |
| External shock to heart to regulate heart beat | 11 | $1,289 | $107 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 21 | $1,194 | $54 |
| Programming of single lead implantable defibrillator system | 13 | $1,169 | $53 |
| Programming of dual lead pacemaker system | 14 | $495 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $205 | $13 |
Medicaid work
$1,452 in 2024
Medicaid paid $1,452 for 284 billed services this clinician did in 2024, up to 114 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 231 | $1,049 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 28 | $251 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 25 | $151 |
| 2024 | 284 | 3 | 114 | $1,452 |
| 2023 | 262 | 1 | 111 | $981 |
| 2022 | 218 | 3 | 74 | $1,029 |
| 2021 | 259 | 1 | 81 | $1,142 |
| 2020 | 129 | 1 | 58 | $599 |
| 2019 | 155 | 1 | 67 | $797 |
| 2018 | 164 | 1 | 79 | $671 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 262 | $981 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 193 | $924 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 13 | $73 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 12 | $32 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 259 | $1,142 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 129 | $599 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 155 | $797 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 164 | $671 |
Drugs they prescribed that Part D paid
$1,168,038
Pharmacies billed $1,168,038 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,363) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
1,468 generic and 895 brand-name prescriptions · $1,168,038 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 628 | $798,850 | $1,272 |
| Xarelto | 186 | $248,834 | $1,338 |
| Multaq | 43 | $74,340 | $1,729 |
| Metoprolol | 492 | $6,444 | $13 |
| Flecainide Acetate | 128 | $6,236 | $49 |
See all 28 drugs
| Eliquis | 628 | $798,850 | $1,272 |
| Xarelto | 186 | $248,834 | $1,338 |
| Multaq | 43 | $74,340 | $1,729 |
| Metoprolol | 492 | $6,444 | $13 |
| Flecainide Acetate | 128 | $6,236 | $49 |
| Diltiazem 24hr Er (Cd) | 110 | $3,523 | $32 |
| Amiodarone | 138 | $3,327 | $24 |
| Mexiletine | 13 | $1,521 | $117 |
| Sotalol | 45 | $741 | $16 |
| Atorvastatin | 55 | $677 | $12 |
| Sotalol Af | 12 | $647 | $54 |
| Lisinopril | 48 | $568 | $12 |
| Verapamil Er | 14 | $556 | $40 |
| Digoxin | 27 | $536 | $20 |
| Carvedilol | 28 | $515 | $18 |
| Metoprolol | 50 | $458 | $9 |
| Losartan | 25 | $423 | $17 |
| Diltiazem 24hr Er | 12 | $368 | $31 |
| Warfarin | 26 | $337 | $13 |
| Amlodipine Besylate | 50 | $329 | $7 |
| Potassium Chloride | 11 | $282 | $26 |
| Atenolol | 19 | $237 | $12 |
| Rosuvastatin | 15 | $226 | $15 |
| Benazepril | 15 | $162 | $11 |
| Bisoprolol | 11 | $156 | $14 |
| Pantoprazole | 26 | $151 | $6 |
| Furosemide | 11 | $73 | $7 |
| Simvastatin | 12 | $27 | $2 |
Year by year
| 2024 | 2,363 | 408 | 0% (0) | 38% | $1,168,038 |
| 2023 | 2,209 | 354 | 0% (0) | 40% | $1,138,127 |
| 2022 | 2,063 | 349 | 0% (0) | 40% | $1,015,434 |
| 2021 | 1,726 | 292 | 0% (0) | 41% | $815,882 |
| 2020 | 1,642 | 261 | 0% (0) | 41% | $656,972 |
| 2019 | 1,623 | 260 | 0% (0) | 40% | $526,917 |
| 2018 | 1,719 | 249 | 0% (0) | 37% | $424,417 |
| 2017 | 1,529 | 230 | 0% (0) | 34% | $270,274 |
| 2016 | 1,297 | 209 | None | 31% | $198,431 |
| 2015 | 1,345 | 190 | None | 28% | $182,044 |
| 2014 | 1,295 | 202 | None | 23% | $153,287 |
| 2013 | 1,437 | 192 | None | 26% | $147,317 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Eliquis | 584 | $725,814 | $1,243 |
| Xarelto | 204 | $274,167 | $1,344 |
| Multaq | 58 | $86,191 | $1,486 |
| Flecainide Acetate | 105 | $9,098 | $87 |
| Metoprolol | 414 | $7,555 | $18 |
| Diltiazem 24hr Er (Cd) | 95 | $5,106 | $54 |
| Propafenone Hcl Er | 13 | $4,339 | $334 |
| Amiodarone | 113 | $3,561 | $32 |
| Sotalol | 56 | $2,519 | $45 |
| Verapamil Sr | 21 | $1,690 | $80 |
| Mexiletine | 12 | $1,575 | $131 |
| Sotalol Af | 18 | $1,303 | $72 |
| Propafenone | 14 | $954 | $68 |
| Fludrocortisone Acetate | 19 | $710 | $37 |
| Bisoprolol | 13 | $685 | $53 |
| Digoxin | 24 | $606 | $25 |
| Atorvastatin | 36 | $605 | $17 |
| Losartan | 41 | $506 | $12 |
| Rosuvastatin | 12 | $448 | $37 |
| Carvedilol | 24 | $429 | $18 |
| Lisinopril | 38 | $365 | $10 |
| Amlodipine Besylate | 54 | $335 | $6 |
| Diltiazem 24hr Er | 15 | $312 | $21 |
| Metoprolol | 39 | $303 | $8 |
| Warfarin | 23 | $263 | $11 |
| Benazepril | 17 | $261 | $15 |
| Atenolol | 19 | $186 | $10 |
| Triamterene-Hydrochlorothiazid | 12 | $176 | $15 |
| Verapamil Er | 12 | $143 | $12 |
| Pantoprazole | 17 | $108 | $6 |
| Furosemide | 16 | $75 | $5 |
2022: 23 drugs
| Eliquis | 533 | $645,449 | $1,211 |
| Xarelto | 195 | $238,104 | $1,221 |
| Multaq | 59 | $69,597 | $1,180 |
| Flecainide Acetate | 117 | $9,862 | $84 |
| Metoprolol | 372 | $7,485 | $20 |
| Diltiazem 24hr Er (Cd) | 120 | $5,541 | $46 |
| Amiodarone | 114 | $4,276 | $38 |
| Sotalol Af | 17 | $2,305 | $136 |
| Sotalol | 56 | $1,917 | $34 |
| Propafenone | 19 | $833 | $44 |
| Diltiazem 24hr Er | 16 | $695 | $43 |
| Digoxin | 20 | $573 | $29 |
| Carvedilol | 31 | $527 | $17 |
| Amlodipine Besylate | 46 | $462 | $10 |
| Atorvastatin | 44 | $423 | $10 |
| Warfarin | 17 | $353 | $21 |
| Metoprolol | 38 | $345 | $9 |
| Pantoprazole | 36 | $287 | $8 |
| Losartan | 29 | $280 | $10 |
| Lisinopril | 32 | $217 | $7 |
| Atenolol | 18 | $177 | $10 |
| Simvastatin | 12 | $77 | $6 |
| Hydrochlorothiazide | 12 | $45 | $4 |
2021: 22 drugs
| Eliquis | 464 | $505,027 | $1,088 |
| Xarelto | 172 | $196,101 | $1,140 |
| Multaq | 63 | $66,632 | $1,058 |
| Flecainide Acetate | 86 | $8,294 | $96 |
| Metoprolol | 307 | $6,592 | $21 |
| Diltiazem 24hr Er (Cd) | 74 | $3,846 | $52 |
| Sotalol | 52 | $2,595 | $50 |
| Amiodarone | 97 | $2,427 | $25 |
| Propafenone | 13 | $2,075 | $160 |
| Cartia Xt | 11 | $750 | $68 |
| Warfarin | 14 | $522 | $37 |
| Digoxin | 15 | $481 | $32 |
| Metoprolol | 38 | $347 | $9 |
| Amlodipine Besylate | 31 | $321 | $10 |
| Carvedilol | 23 | $300 | $13 |
| Atorvastatin | 21 | $299 | $14 |
| Atenolol | 21 | $281 | $13 |
| Bisoprolol | 11 | $269 | $24 |
| Losartan | 26 | $257 | $10 |
| Pantoprazole | 33 | $241 | $7 |
| Lisinopril | 30 | $233 | $8 |
| Hydrochlorothiazide | 12 | $38 | $3 |
2020: 25 drugs
| Eliquis | 408 | $392,617 | $962 |
| Xarelto | 206 | $183,057 | $889 |
| Multaq | 21 | $23,376 | $1,113 |
| Pradaxa | 11 | $10,709 | $974 |
| Propafenone Hcl Er | 13 | $9,048 | $696 |
| Flecainide Acetate | 84 | $8,374 | $100 |
| Diltiazem 24hr Er (Cd) | 86 | $7,197 | $84 |
| Metoprolol | 272 | $7,032 | $26 |
| Amiodarone | 89 | $2,764 | $31 |
| Propafenone | 19 | $2,125 | $112 |
| Sotalol | 35 | $1,363 | $39 |
| Digoxin | 24 | $1,028 | $43 |
| Warfarin | 26 | $870 | $33 |
| Cartia Xt | 14 | $651 | $47 |
| Metoprolol | 60 | $441 | $7 |
| Amlodipine Besylate | 31 | $367 | $12 |
| Atorvastatin | 14 | $343 | $25 |
| Carvedilol | 22 | $324 | $15 |
| Atenolol | 25 | $250 | $10 |
| Losartan | 24 | $229 | $10 |
| Lisinopril | 12 | $172 | $14 |
| Bisoprolol | 11 | $158 | $14 |
| Pantoprazole | 11 | $100 | $9 |
| Furosemide | 18 | $85 | $5 |
| Hydrochlorothiazide | 14 | $65 | $5 |
2019: 25 drugs
| Eliquis | 402 | $314,578 | $783 |
| Xarelto | 163 | $134,506 | $825 |
| Pradaxa | 25 | $17,304 | $692 |
| Multaq | 16 | $16,774 | $1,048 |
| Metoprolol | 311 | $9,326 | $30 |
| Flecainide Acetate | 70 | $7,610 | $109 |
| Diltiazem 24hr Er (Cd) | 64 | $2,515 | $39 |
| Mexiletine | 15 | $2,254 | $150 |
| Sotalol | 39 | $1,943 | $50 |
| Propafenone | 14 | $1,719 | $123 |
| Cartia Xt | 46 | $1,716 | $37 |
| Amiodarone | 70 | $1,367 | $20 |
| Sotalol Af | 19 | $1,152 | $61 |
| Digoxin | 19 | $1,085 | $57 |
| Warfarin | 43 | $979 | $23 |
| Metoprolol | 45 | $515 | $11 |
| Atorvastatin | 17 | $496 | $29 |
| Carvedilol | 14 | $338 | $24 |
| Amlodipine Besylate | 30 | $270 | $9 |
| Lisinopril | 15 | $239 | $16 |
| Losartan | 21 | $232 | $11 |
| Hydrochlorothiazide | 20 | $229 | $11 |
| Furosemide | 23 | $170 | $7 |
| Atenolol | 15 | $136 | $9 |
| Omeprazole | 12 | $59 | $5 |
2018: 30 drugs
| Eliquis | 301 | $196,263 | $652 |
| Xarelto | 180 | $121,736 | $676 |
| Pradaxa | 62 | $44,301 | $715 |
| Metoprolol | 350 | $10,398 | $30 |
| Flecainide Acetate | 82 | $9,377 | $114 |
| Multaq | 12 | $7,817 | $651 |
| Amiodarone | 72 | $2,896 | $40 |
| Diltiazem 24hr Er (Cd) | 36 | $2,876 | $80 |
| Sotalol Af | 24 | $2,179 | $91 |
| Cartia Xt | 55 | $1,930 | $35 |
| Propafenone | 14 | $1,715 | $122 |
| Digoxin | 19 | $1,187 | $62 |
| Digox | 18 | $1,131 | $63 |
| Warfarin | 43 | $876 | $20 |
| Sotalol | 35 | $808 | $23 |
| Mexiletine | 11 | $778 | $71 |
| Atorvastatin | 21 | $523 | $25 |
| Metoprolol | 38 | $338 | $9 |
| Amlodipine Besylate | 52 | $336 | $6 |
| Diltiazem 24hr Er | 13 | $324 | $25 |
| Carvedilol | 18 | $297 | $17 |
| Klor-Con 10 | 12 | $212 | $18 |
| Omeprazole | 29 | $191 | $7 |
| Lisinopril | 18 | $166 | $9 |
| Losartan | 23 | $158 | $7 |
| Hydrochlorothiazide | 23 | $141 | $6 |
| Atenolol | 14 | $138 | $10 |
| Furosemide | 25 | $121 | $5 |
| Diltiazem | 12 | $107 | $9 |
| Losartan-Hydrochlorothiazide | 12 | $99 | $8 |
2017: 28 drugs
| Eliquis | 180 | $95,988 | $533 |
| Xarelto | 104 | $66,169 | $636 |
| Pradaxa | 76 | $41,141 | $541 |
| Propafenone Hcl Er | 20 | $13,982 | $699 |
| Metoprolol | 297 | $9,196 | $31 |
| Flecainide Acetate | 97 | $7,631 | $79 |
| Sotalol Af | 42 | $3,609 | $86 |
| Amiodarone | 65 | $3,218 | $50 |
| Diltiazem 24hr Er | 44 | $2,562 | $58 |
| Propafenone | 17 | $2,136 | $126 |
| Mexiletine | 15 | $1,926 | $128 |
| Cartia Xt | 55 | $1,721 | $31 |
| Digox | 24 | $1,695 | $71 |
| Digoxin | 29 | $1,659 | $57 |
| Warfarin | 60 | $1,399 | $23 |
| Sotalol | 37 | $599 | $16 |
| Atorvastatin | 20 | $474 | $24 |
| Metoprolol | 46 | $342 | $7 |
| Potassium Chloride | 16 | $289 | $18 |
| Klor-Con 10 | 14 | $215 | $15 |
| Carvedilol | 19 | $157 | $8 |
| Clopidogrel | 14 | $142 | $10 |
| Amlodipine Besylate | 23 | $136 | $6 |
| Atenolol | 28 | $122 | $4 |
| Hydrochlorothiazide | 19 | $115 | $6 |
| Lisinopril | 25 | $113 | $5 |
| Omeprazole | 17 | $108 | $6 |
| Furosemide | 20 | $64 | $3 |
2016: 27 drugs
| Xarelto | 112 | $61,222 | $547 |
| Eliquis | 80 | $43,019 | $538 |
| Pradaxa | 64 | $33,506 | $524 |
| Propafenone Hcl Er | 21 | $12,561 | $598 |
| Multaq | 19 | $10,909 | $574 |
| Metoprolol | 235 | $7,495 | $32 |
| Flecainide Acetate | 80 | $3,895 | $49 |
| Diltiazem 24hr Er | 47 | $2,798 | $60 |
| Amiodarone | 63 | $2,781 | $44 |
| Cartia Xt | 42 | $1,838 | $44 |
| Sotalol Af | 41 | $1,696 | $41 |
| Enoxaparin | 19 | $1,594 | $84 |
| Propafenone | 15 | $1,510 | $101 |
| Warfarin | 73 | $1,163 | $16 |
| Digoxin | 16 | $1,038 | $65 |
| Digox | 14 | $849 | $61 |
| Metoprolol | 48 | $813 | $17 |
| Clopidogrel | 18 | $472 | $26 |
| Sotalol | 23 | $425 | $18 |
| Atorvastatin | 19 | $395 | $21 |
| Amlodipine Besylate | 23 | $172 | $7 |
| Klor-Con 10 | 14 | $160 | $11 |
| Atenolol | 34 | $157 | $5 |
| Lisinopril | 24 | $157 | $7 |
| Omeprazole | 13 | $119 | $9 |
| Hydrochlorothiazide | 11 | $83 | $8 |
| Furosemide | 15 | $74 | $5 |
2015: 29 drugs
| Xarelto | 119 | $52,645 | $442 |
| Propafenone Hcl Er | 41 | $25,699 | $627 |
| Pradaxa | 39 | $22,813 | $585 |
| Eliquis | 54 | $22,238 | $412 |
| Multaq | 36 | $18,491 | $514 |
| Metoprolol | 196 | $7,368 | $38 |
| Flecainide Acetate | 91 | $5,743 | $63 |
| Amiodarone | 83 | $2,804 | $34 |
| Enoxaparin | 21 | $2,356 | $112 |
| Warfarin | 85 | $2,068 | $24 |
| Digox | 36 | $1,883 | $52 |
| Cartia Xt | 35 | $1,796 | $51 |
| Propafenone | 19 | $1,693 | $89 |
| Diltiazem 24hr Er | 45 | $1,674 | $37 |
| Mexiletine | 12 | $1,312 | $109 |
| Diltiazem 24hr Cd | 29 | $1,281 | $44 |
| Diltiazem Er | 15 | $1,118 | $75 |
| Sotalol Af | 26 | $1,003 | $39 |
| Potassium Chloride | 21 | $693 | $33 |
| Sotalol | 21 | $549 | $26 |
| Metoprolol | 40 | $516 | $13 |
| Atorvastatin | 25 | $475 | $19 |
| Clopidogrel | 18 | $346 | $19 |
| Atenolol | 26 | $271 | $10 |
| Lisinopril | 40 | $247 | $6 |
| Amlodipine Besylate | 25 | $143 | $6 |
| Furosemide | 29 | $121 | $4 |
| Omeprazole | 11 | $79 | $7 |
| Simvastatin | 11 | $42 | $4 |
2014: 29 drugs
| Pradaxa | 95 | $47,161 | $496 |
| Xarelto | 77 | $30,439 | $395 |
| Propafenone Hcl Er | 42 | $17,477 | $416 |
| Multaq | 26 | $11,279 | $434 |
| Metoprolol | 179 | $8,297 | $46 |
| Enoxaparin | 43 | $7,067 | $164 |
| Flecainide Acetate | 114 | $5,272 | $46 |
| Diltiazem 24hr Er | 40 | $2,250 | $56 |
| Digox | 35 | $2,099 | $60 |
| Warfarin | 112 | $1,965 | $18 |
| Diltiazem Er | 40 | $1,938 | $48 |
| Propafenone | 21 | $1,910 | $91 |
| Amiodarone | 73 | $1,662 | $23 |
| Diltiazem 24hr Cd | 11 | $1,207 | $110 |
| Sotalol Af | 25 | $907 | $36 |
| Digoxin | 14 | $868 | $62 |
| Cartia Xt | 16 | $846 | $53 |
| Sotalol | 23 | $765 | $33 |
| Clopidogrel | 11 | $736 | $67 |
| Losartan | 14 | $627 | $45 |
| Metoprolol | 39 | $436 | $11 |
| Atorvastatin | 17 | $420 | $25 |
| Potassium Chloride | 13 | $376 | $29 |
| Lisinopril | 33 | $304 | $9 |
| Atenolol | 23 | $253 | $11 |
| Carvedilol | 14 | $226 | $16 |
| Amlodipine Besylate | 24 | $218 | $9 |
| Omeprazole | 16 | $146 | $9 |
| Furosemide | 13 | $53 | $4 |
2013: 29 drugs
| Pradaxa | 164 | $61,438 | $375 |
| Propafenone | 56 | $16,269 | $291 |
| Enoxaparin | 53 | $11,573 | $218 |
| Multaq | 26 | $10,014 | $385 |
| Metoprolol | 220 | $9,126 | $41 |
| Xarelto | 31 | $8,696 | $281 |
| Flecainide Acetate | 91 | $5,290 | $58 |
| Diltiazem Er | 36 | $2,284 | $63 |
| Warfarin | 121 | $2,015 | $17 |
| Cartia Xt | 49 | $2,008 | $41 |
| Diltiazem 24hr Er | 25 | $1,712 | $68 |
| Amiodarone | 77 | $1,181 | $15 |
| Sotalol | 24 | $987 | $41 |
| Sotalol Af | 27 | $951 | $35 |
| Clopidogrel | 15 | $758 | $51 |
| Losartan | 18 | $689 | $38 |
| Atorvastatin | 18 | $673 | $37 |
| Potassium Chloride | 13 | $613 | $47 |
| Diltiazem 24hr Cd | 15 | $610 | $41 |
| Lanoxin | 12 | $595 | $50 |
| Carvedilol | 32 | $489 | $15 |
| Amlodipine Besylate | 37 | $404 | $11 |
| Lisinopril | 20 | $341 | $17 |
| Metoprolol | 31 | $300 | $10 |
| Digox | 21 | $259 | $12 |
| Omeprazole | 16 | $248 | $16 |
| Atenolol | 29 | $235 | $8 |
| Digoxin | 27 | $199 | $7 |
| Furosemide | 20 | $112 | $6 |
Money from drug and device companies
$331 in 2025
| 2025 | 3 | 10 | None | $331 |
| 2024 | 1 | 1 | None | $34 |
| 2023 | 1 | 1 | None | $27 |
| 2022 | 2 | 4 | None | $81 |
| 2020 | 1 | 1 | None | $19 |
| 2019 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biosense Webster | Carto 3 | $155 | 6 payments
|
| Medtronic | Selectsecure | $128 | 2 payments
|
| Abbott Laboratories | Agilis | $48 | 2 payments
|
See all 10 published payments
| Biosense Webster | Meals · 2025-10-09 | Carto 3 | $27 |
| Abbott Laboratories | Meals · 2025-09-09 | Triclip | $24 |
| Abbott Laboratories | Meals · 2025-08-01 | Agilis | $25 |
| Biosense Webster | Meals · 2025-07-23 | Carto 3 | $33 |
| Biosense Webster | Meals · 2025-05-19 | Carto 3 | $22 |
| Biosense Webster | Meals · 2025-05-16 | Carto 3 | $30 |
| Medtronic | Meals · 2025-05-02 | Affera Mapping System | $34 |
| Biosense Webster | Meals · 2025-05-01 | Carto 3 | $22 |
| Medtronic | Meals · 2025-04-23 | Selectsecure | $93 |
| Biosense Webster | Meals · 2025-03-04 | Carto 3 | $22 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $34
| Biosense Webster | Carto 3 | $34 | 1 payment
|
2023: $27
| Cardiva Medical | Cardiva Vascade 6/7f Vcs | $27 | 1 payment
|
2022: $81
| Abbott Laboratories | Vantageview | $43 | 2 payments
|
| Biosense Webster | Octaray Mapping Catheter | $38 | 2 payments
|
2020: $19
| Endologix | Ovation | $19 | 1 payment
|
2019: $14
| Biosense Webster | Carto 3 System | $14 | 1 payment
|
Professional record
- NPI
- 1477640381
- Licence
- CA G69787California G69787: Current · expires 2027-10-31
- Trained
- George Washington University School of Medicine, 1989
- Group
- Physician Services at El Camino Hospital · Sutter Bay Medical Foundation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-10-10
- NPI last updated
- 2024-04-18
- NPI record certified
- 2024-04-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 795 El Camino Real, Palo Alto, CA, 94301 · 87 Encina Ave, Palo Alto, CA, 94301